SWK Holdings Co. (NASDAQ:SWKH - Get Free Report) shares fell 4.1% during mid-day trading on Friday . The company traded as low as $15.63 and last traded at $15.80. 67,931 shares changed hands during trading, an increase of 530% from the average session volume of 10,786 shares. The stock had previously closed at $16.47.
SWK Trading Down 4.1 %
The firm has a market capitalization of $193.28 million, a price-to-earnings ratio of 16.99 and a beta of 0.35. The business's 50-day moving average price is $16.36 and its 200 day moving average price is $16.80. The company has a debt-to-equity ratio of 0.11, a current ratio of 5.06 and a quick ratio of 5.06.
Hedge Funds Weigh In On SWK
Institutional investors have recently added to or reduced their stakes in the company. SkyView Investment Advisors LLC boosted its stake in shares of SWK by 7.7% during the 2nd quarter. SkyView Investment Advisors LLC now owns 31,165 shares of the company's stock valued at $529,000 after buying an additional 2,234 shares during the last quarter. Barclays PLC boosted its stake in SWK by 185.0% during the 3rd quarter. Barclays PLC now owns 4,461 shares of the company's stock valued at $77,000 after acquiring an additional 2,896 shares during the last quarter. Bank of New York Mellon Corp bought a new position in shares of SWK during the second quarter worth about $172,000. Dimensional Fund Advisors LP lifted its holdings in SWK by 85.7% during the 2nd quarter. Dimensional Fund Advisors LP now owns 30,109 shares of the company's stock worth $511,000 after buying an additional 13,892 shares during the last quarter. Finally, Victory Capital Management Inc. acquired a new stake in shares of SWK during the 3rd quarter valued at approximately $589,000. Institutional investors and hedge funds own 99.27% of the company's stock.
About SWK
(
Get Free Report)
SWK Holdings Corporation, offers specialty finance and asset management services in the United States. It operates in two segments, Finance Receivables and Pharmaceutical Development. The Finance Receivables segment provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors.
Featured Stories
Before you consider SWK, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SWK wasn't on the list.
While SWK currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
